ST14 and prostate carcinoma: Since it has been suggested that HAI-2 serves as a more effective inhibitor on matriptase than HAI-190, our results support that HAI-2’s KD1 may have a therapeutic potential to be a potent inhibitor for matriptase and prostate cancer invasive growth.